Mizuho analyst Ann Hynes raised the firm’s price target on Centene (CNC) to $58 from $50 and keeps a Neutral rating on the shares. The firm views the Q1 reports in the manage care group as solid. It cites a reduced likelihood of negative medical loss ratio shifts through the end of 2026 for the target bump.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC: